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AbbreviAtion
BSA Bovine serum albumin
PBS Phosphate buffer saline
PFA Paraformaldehyde
RT Room Temperature
SEM Standard error of mean 
2-DE Two-Dimensional Electrophoresis 
CHAPS 3-[(3- Cholamidopropyl) dimethylammoniol]-1- 
propanesulfonate; 
DTT dithioreitol
TCA Tricholoroacetic acid
SDS Sodium dodecylsulfate
IEF Isoelectric focusing
1. introduction
Nanotechnology includes a material with the smallest 
unit of nanometre scale, ranging from 1-100 nm1. At the 
nanometer scale, many materials possess novel properties 
that are exploited in various applications2. With the increasing 
production of engineered nanoparticles (NPs), their release 
into the environment is drastically increased. It is important to 
study the adverse effects of the release of nanoparticles on the 
environment and human health3 . The interaction of NPs with 
human tissues has not been fully elucidated. Nanoparticles 
have more surface area per unit mass, which make them 
very reactive in the cellular environment4.  Humans can 
come in contact with NPs through inhalation; ingestion and 
absorption through skin5,6. Toxicity induced by engineered 
NPs remains debatable. Many questions remain unanswered 
concerning fate, communication and interactions of NPs with 
human cells.
Zinc oxide (ZnO) NPs with mystic properties are 
widely used in commercial products like textiles, plastic, 
paints, cosmetics, UV light blockers and medical supplies7,8. 
Toxicological studies on ZnO NPs have been conducted on 
various cell lines like human broncho-alveolar carcinoma 
derived cells, human lymphoblastoid cell line TK6, Chinese 
hamster ovary cells, human hepatocyte (L02) and human 
embryonic kidney (HEK293) cells; these studies primarily 
demonstrated oxidative stress, genotoxicity and homeostatic 
imbalance9-12. Due to high surface area and reactivity, NPs 
frequently interact with proteins and eventually these 
interactions can lead to conformational changes or loss of 
functionality of interacting or associated proteins. In the 
present report the differential proteomic response in A549 
cells, on exposure to ZnO NPs was studied. The data indicated 
diverse patterns of cellular responses arising on exposure to the 
ZnO NPs and highlighted uncharacterised cellular phenomena. 
ZnO NPs have shown to induce cellular and morphological 
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modifications along with mitochondrial dysfunction and 
oxidative stress13. Through this study, we made an attempt 
to find the proteins regulating such mechanisms with a keen 
focus on protein related to the cytoskeleton. The outcome of 
this work will possibly be useful to determine the toxicity and 
biocompatibility of ZnO NPs, and enhance the understanding 
of nano-bio interactions.
2. MEtHODs
2.1 ZnO NPs Dispersion and Characterisation 
The commercially purchased ZnO nanopowder (<50 
nm) (Sigma Chemicals Co. Ltd.) were characterised on the 
basis of shape, size and stability by DLS and TEM. ZnO 
NPs dispersion was prepared in MilliQ water and cell culture 
medium, and ultra sonicated (ElmasonicS 30/H) for 10 min 
at 37 KHz. Hydrodynamic radii of the particles in dispersion 
was measured through dynamic light scattering with Malvern 
Zetasizer Nano-ZS (Malvern, U.S.A.). To determine the 
particle size and morphology, a drop of dispersion of NPs in 
MilliQ water was casted on 300 mesh carbon coated grid, air 
dried and visualised through TEM (MORGANI Instrument) at 
accelerating voltage of 200 KV.
2.2 Exposure of A549 Cells to ZnO NPs 
The human lung carcinoma cell line (A549) was obtained 
from National Centre for Cell Sciences (Pune, India), tested 
for mycoplasma and endotoxin contamination and maintained 
at culture condition as given in Jain13, et al.  Lung carcinoma 
epithelial cells were cultured in Dulbecco’s Modified Eagle’s 
Medium high glucose supplemented with 10 % FBS, 100 
unit mL-1 penicillin, 100 unit mL-1 streptomycin respectively. 
For proteomic studies, freshly prepared dispersion of 1 mg/
ml ZnO NPs was diluted with cell culture media in required 
concentrations of 100 µg/ml, and added to A549 cells, and 
cells were cultured for 4 h at normal culturing conditions. 
Cells without ZnO NPs in culture media were considered as 
control.
2.3 sample Preparation for Proteomics Analysis 
In order to collect the cells for protein isolation, 0.1M 
PBS was added to cells that were scraped from the surface of 
the plate with a rubber policeman. The collected cells were 
centrifuged for 10 min at 300 g at 4 °C. Cell lysate was prepared 
by adding 200 µl of lysis buffer containing 40 mM Tris, 0.1 % 
NP 40, protease inhibitor cocktail and incubated for 30 min on 
ice. The lysed cells were centrifuged at 15000 g for 20 min and 
supernatant containing protein was collected14,15.
2.4 Protein Precipitation with 10 % tCA 
10 % TCA  prepared in ice cold acetone was added to 
the protein supernatant in the ratio of 1:10 and incubated 
overnight at -20 °C. Pellet of precipitated protein was 
collected by centrifugation at 15,000 g for 10 min at 4 °C. 
The pellet was washed by incubating with 500 µl of 90 % 
ice cold acetone containing 20 mM DTT, for 10 min at -20 
°C and centrifuged at 15000 g for 15 min at 4 °C. The pellet 
was washed repeatedly until clear white and then air dried. 
The pellet was dissolved in 100 µl of rehydration buffer (8 
M urea, 2 % CHAPS, 0.2 % ampholyte, 50 mM DTT), 
quantified with Bradford assay and stored at -80 °C until 
further analysis16.
2.5 two-dimensional Gel Electrophoresis for 
Protein separation
First dimensional gel separation was performed by 
rehydrating  7 cm, pH 4-7 IPG strip with 100 µg of protein 
in 125 µl of rehydration buffer (8 M urea, 2 % CHAPS, 
0.2% ampholyte, 50 mM DTT, 0.001 % bromophenol blue) 
for 12 h. Isoelectric focussing was carried out at 100V, 30 
min, rapid; 200-3500V, 1.5 h, gradient; 3500 V, 1-1.5 h, 
rapid and 500 V hold17. The strip was equilibrated with first 
equilibration buffer (50 mM Tris-HCL, pH 8.8, 6 M urea, 30 
% glycerol (v/v), 2 % SDS (w/v), 1% DTT (w/v) and second 
equilibration buffer (DTT replaced with 2.5 % iodoacetamide) 
for 15 minutes. Second dimensional separation of proteins 
through electrophoresis was done on precasted gradient gels 
(4-20 %) at 100 V. The protein spots were visualised by silver 
staining and scanned image was analysed through Progenesis 
SameSpots and 2D gel image analysis software. Protein spots 
were analysed automatically and rechecked manually to ensure 
spots detection, matching and alignment. Detected protein spots 
with more than 1.5 fold difference and p<0.05 were selected for 
 MALDI analysis.
2.6 In-gel Digestion and MALDI
In gel digestion was carried out to extract the peptide as 
per protocol described by Rubporn18. Briefly, proteins spots 
were excised from the gel and intensively washed with water. 
The excised spots were destained with 30 mM potassium 
ferric cyanide and 100 mM sodium thiosulphate for 30 min. 
The gel pieces were washed with water and 50 mM ammonium 
bicarboante/acetonitrile and incubated with 20 µl trypsin (1 
µg/µL stock concentration, Promega Cooperation, Wisconsin, 
USA) at 37 °C for overnight followed by sonication for 10 
min. The peptides were extracted with 0.1 % TCA and air 
dried in a speed vac. The peptide mixture was mixed with 
cyano-4 hydroxy-cinnamic acid matrix in a ratio of 1:1, 
spotted on MALDI plate and allowed to air dry. Mass standard 
were used to calibrate the instrument, peptide spectrum of 
the sample was further acquired through MALDI TOF/TOF 
(Ultraflex III, Bruker Daltonics, Bremen, Germany) 
at accelerating voltage of 25 KV in positive ion 
mode. The peptide data was exported and analysed 
through Biotools version 3.1, (Bruker Daltonics), Flex 
analysis 3.0 software and MASCOT search engine. 
The peptides were further identified using SWISS-PROT 
database with taxonomy as Homo sapiens, peptide mass 
tolerance of 100 ppm, maximum one missed cleavage 
site permitted and carbamidomethyl fixed modification as 
search parameters. The data obtained was further analysed 
for protein protein interaction using ToppGene suite. 
To understand the functional pathways related to the expressed 
proteins, the data set was analysed through PANTHER (Protein 
ANalysis THrough Evolutionary Relationship) software. 
The proteins were identified with UniProt accession dataset 
against the Homo sapiens reference dataset. The differentially 
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expressed proteins are classified into group of gene ontology, 
based on molecular function, biological process and cellular 
component. The differentially expressed proteins were also 
analysed for PANTHER pathway and protein class using 
PANTHER software.
2.7 Effect on cellular morphology on exposure to 
ZnO NPs
To study the change in cell morphology in reference to the 
proteomics data, expression of β tubulin was studied in A549 
cells at 50 μg/ml and 100 μg/ml concentration of ZnO NPs. 
Approximatly, 1 x 105 /cm2 cells were cultured on the coverslips 
and treated with 100 µg/ml and 50 μg/ml concentration of ZnO 
NPs individually for the period of 4 hours. The treated cells 
were further fixed with 3.7 % formaldehyde in 1X PBS for 5 
min, washed thrice with 1X PBS and permeabilised with 0.1 % 
Triton X-100 in 1X PBS for 3 min. After washing thrice with 
1X PBS, the cover slips were then blocked with 3 % bovine 
serum albumin in 1X PBS for 30 min at room temperature. 
Microtubulins were stained with mouse monoclonal anti β 
tubulin antibody  at 1:100 dilution, subsequently the cells were 
incubated with FITC secondary antibody at 1:100 concentration. 
The images were acquired through a fluorescence microscope 
(Olympus BX51).
2.8 statistical Analysis
All experiments were performed in triplicate with 
quantitative data represented as ± standard error of mean. 
Statistical analysis was done through Student’s t-test using 
Graph Pad Prism software with statistically significant data 
with p-value < 0.05.Volcano plot was constructed to visualize 
differentiation protein expression using double filter criterion 
with negative log of the p-values on the y-axis (base 10), 
where the data points with low p-values i.e. considered being 
highly significant appears at the top of the plot. The values of 
log2 of the fold-change between the control and treated were 
plotted on the x axis. Fold change of ± 2 was considered to 
screen proteins with differential expression. Identical peptide 
quotients of the similar proteins were averaged and different 
peptides belonging to the same protein were averaged to 
determine the fold change.
3. REsuLts
3.1 Characterisation of ZnO NPs 
Each particle behaves differently in biological media 
depending on its size and morphology. Distribution of these 
particles by intensity, volume in DMEM was measured by 
dynamic light scattering and transmission electron microscopy, 
showed no agglomerations13,19. ZnO NPs were spherically 
shaped with estimated size 23±3 nm. The hydrodynamic size 
of the particles was 110±2 nm with polydispersity index of 0.2 
as determined through DLS as shown in Fig. 1.  
3.2 Protein Profiling of Cells Exposed to ZnO NPs
A549 cells are human carcinoma alveolar basal epithelial 
cells that grow as monolayer adherent to the culture flask. 
Proteomic analysis was done on cell lysate of A549 cell treated 
with ZnO NPs at 100 µg/ml concentration for 4 h. The 2D 
gel electrophoresis was performed five times on control A549 
cells and ZnO NPs exposed A549 cells. The representative 
protein pattern of A549 cells was shown in Fig. 2. An average 
of 185 and 163 spots was detected in control and ZnO NPs 
exposed cells, respectively. 22 differentially expressed protein 
spots were excised and digested with trypsin. The trypsinised 
peptides were further analysed by MALDI-TOF/TOF. A total of 
twenty two proteins from both cells were identified by MS/MS. 
Details of the differential protein expression in exposed and 
control cells were listed in Table 1. Eleven proteins were over 
expressed and eleven proteins were under expressed in ZnO 
exposed A549 cells by approximately 2-4 folds .The interaction 
map of differentially expressed proteins was generated through 
ToppGene suite as shown in Fig. 3. Differentially expressed 
proteins were broadly grouped into two categories; heat shock 
proteins and proteins related to the cytoskeleton. 
3.3 Gene Ontology Analysis of Differentially 
Expressed Proteins
A cumulative result of the proteins with differential 
expression is illustrated in a volcano plot as shown in Fig. 4. 
 The proteins were further identified on the basis of  Gene 
ontology term GO biological process;  immune system 
process, development process, cellular process, multicellular 
organismal process, metabolic process, cellular component 
Figure 1.  (a) tEM image showing mono dispersed particles with an average size of 23 ± 3 nm and (b) Evaluation of hydrodynamic 
size and poly-dispersity index through dynamic light scattering.
(a) (b)
Size distribution by intensity
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organisation and localisation GO molecular process; binding, 
structural molecule activity, catalytic activity and transporter 
activity; GO cellular component; macromolecular complex, 
cell part, organelle. PANTHER analysis was also done for 
protein class and cellular pathways, protein grouped into 
class of signalling molecule, transporter protein, cytoskeletal 
protein, chaperone, enzyme modulator, structural protein, 
oxidoreductase and membrane traffic protein. Proteins 
regulating cellular pathways like cadherin signalling pathway, 
Interleukin signalling pathway, apoptosis signalling pathway, 
intergrin pathways, Alzheimer disease presenilin pathway, 
Huntington disease, inflammation mediated by chemokine 
and cytokine signalling pathways, wnt signalling pathway, 
Parkinson’s disease, cytoskeleton regulation by Rho GTPase 
and Nicotine acetycholine receptor signalling pathways were 
altered on exposure with ZnO NPs as shown in Fig. 5.
To find relevant proteins among the multiple identifications 
obtained from proteomic analysis, we subjected the list of 
the 22 different proteins from Table 1 to bioinformatics 
analysis in the STRING database, which integrates interaction 
data from several bioinformatics sources and provides 
information about physical and functional properties, known 
and predicted interactions of genes and their products. Ten 
additional interacting proteins were added to provide a more 
comprehensive view of the interactions as shown in Fig. 6. 
3.4 Effect on Cellular Morphology on Exposure to 
ZnO NPs 
Contraction of cells was observed when stained with 
β-tubulin, indicating alteration of cytoskeleton structure on 
exposure to ZnO NPs as shown in Fig. 7. Control cells showed 
the normal microtubule network, whereas on exposure to ZnO 
Figure 2. A representative 2-DE gel image of A549 cells exposed 
to ZnO-NPs (100 µg). Proteins (200 µg) were separated 
by IEF using pH 4-7, 7 cm IPG strips (Bio-rad) and 
4-20% gradient gel. the gels were silver stained and 
analysed by Progenesis samespots 2-D gel image 
analysis software. Right indicate the migration 
of molecular mass standard (thermo scientific™ 
Pierce™ unstained Protein MW Marker Catalog 
number:26610). spot number represents differentially 
expressed proteins (± 2 fold, p<0.05) in ZnO exposed 
cells compared to control.
Figure 3. Zoom-in images of 2-D gel image of differentially 
expressed spots in control and ZnO-NPs exposed cells. 
spots were identified by Ms/Ms. Interaction maps 
of differentially expressed proteins showing their 
interacting partners, using the toppGene suite.
Figure 4. Volcano plot analysis showing differential protein 
expression in A549 cells treated with ZnO NPs. the 
relative level of protein expression after treatment 
is determined through statistical difference and fold 
change. the protein of interest are those away from 
the origin .the protein with increased expression 
are represented by open triangles while protein with 
decreased expression are represented by filled triangles. 
X axis shows the log2 of fold-change of the quotient 
ZnO-NPs exposed/control, whereas the y axis shows 
the − log10 of the calculated probability (p<0.05value), 
associated with student’s t-test. 
Log2 (Fold Change)
-4     -2       0  2    4 
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NPs, cells with damaged and disrupted morphology were 
observed. On exposure to ZnO NPs, shrinkage of cell were 
observed. In the control samples the microtubule network 
was well extended displaying normal cytoskeleton structure 
whereas in ZnO NPs treated cells this network was damaged 
and shrunken.  Depolymerisation of the cytoskeleton and 
cell shrinkage are characteristic of apoptotic cell20. These 
observations postulate interaction of NPs with cytoskeleton 
related protein which also correlates with the results of 
proteomic analysis.
4. DIsCussION
In the present study differential protein expression 
was obtained when A549 cells were exposed to ZnO NPs. 
We aimed to exploit the protein data to understand the 
cellular response of A549 cells to ZnO NPs. ZnO NPs are 
reported to induce oxidative stress, apoptosis, cell membrane 
disruption, lipid peroxidation and mitochondrial dysfunction 
12,20. Bioinformatics analysis of the data revealed that the 
altered proteins have diverse molecular functions, which 
suggests alteration of whole cellular proteome on ZnO-NPs 
exposure. The differential protein profile obtained as shown in 
Table 1 can be summarised into four categories; protein related 
to oxidative stress, mitochondria, folding and cytoskeleton. 
The heat shock proteins (Hsp) are molecular chaperones that 
mediate protein folding, transport and formation of protein 
structures that help the cells to survive in external stress. 
These include Hsp60, Hsp70, Hsp90, Hsp100 and Hsp110, 
each with a specific function. Hsp60 (chaperonin 60) and 
Hsp70 (cognate 11 proteins) were found to be significantly 
over expressed in the protein profile of A549 cells exposed 
with ZnO NPs. Over expression of these two proteins indicate 
towards the oxidative stress induced by the ZnO NPs. Hsp60 
functions as a chaperone only in the mitochondria, which 
directs toward mitochondria as the target organelle effected by 
the ZnO NPs resulting in generation of free radicals. Hsp70 
table 1. Differential protein expression in A549 cells treated with ZnO NPs
Protein description
Accession 
no.
Mol. 
Wt.
Fold 
change
Mowse 
score
Gene function
3-hydroxyisobutyrate dehydrogenase, 
mitochondrial P31937 35705 -1.5 38 Amino acid degradation pathway enzyme
6.8 kDa mitochondrial proteolipid P56378 6658 -1.8 29 Component of an ATP synthase complex
60 kDa heat shock protein, mitochondrial P10809 61016 3.8 64 Chaperonin, protein import, response to stress
Actin, cytoplasmic 1 P60709 42052 -1.8 84 Cell motility
Actin, cytoplasmic 2 P63261 42108 -2.4 88 Cell motility
Condensin complex subunit 3 Q9BPX3 115345 -1.5 28 Regulatory subunit of condensing, helps in cell division
FAD-dependent oxidoreductase domain-
containing protein Q96CU9 78085 -1.7 37 Oxidoreductase activity
Heat shock cognate 71 kDa protein P11142 71082 2.3 81 Chaperon, regulation of transcription, response to stress
Keratin, type I cytoskeletal 10 P13645 59020 -2.6 64 Keratinocyte differentiation, calcium ion response
Keratin, type II cytoskeletal 2 P35908 65678 -3.8 62 Keratinocyte activation, terminal 
cornification
Keratin, type II cytoskeletal 7 P08729 51411 -1.8 60 Blocks interferon-dependent interphase and stimulates DNA synthesis
Metallothionein-2 P02795 7178 2.2 17 Metal metabolism and regulated by glucocorticoid
Pro-interleukin-16 Q14005 142976 1.2 96 Stimulates a migratory response in lymphocytes
Protein bicaudal D homolog 1 Q96G01 111252 1.7 42 Regulates coat complex coatomer protein I
Ras association domain-containing protein 2 P50749 37938 1.8 26 Potential tumour suppressor
Ras-related protein Rab-6A P20340 23692 1.8 81 Protein transport
Thymosin beta-15A P0CG34 5283 1.9 34 Organisation of the cytoskeleton
Tubulin beta chain P10876 50095 -2.9 151 Microtubules
Vesicular integral-membrane protein VIP36 Q12907 40545 1.7 28 Intracellular lectin, involved in the transport and sorting of glycoproteins
Vimentin P08670 53676 -2.1 44 Class-III intermediate filaments
Voltage-dependent anion-selective channel 
protein 2 P45880 32060 1.9 28
Forms a channel through the mitochondrial 
outer membrane
Voltage-gated potassium channel subunit 
beta-2 Q13303 41259 1.7 31 Accessory potassium channel protein
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Figure 5. Categorisation of differentially expressed proteins based on gene ontology and pathways in ZnO-NPs exposed A549 cells 
compare to control, using PANtHER software  (a) GO Biological process, (b) GO Molecular function, (c) GO Cellular 
component, (d) Protein class, (e) Pathway analysis.
Figure 6. Bioinformatics analysis by search tool for the Retrieval of Interacting Genes/Proteins. the list of the identified protein was 
subjected to stRING analysis to reveal functional interactions between the deregulated proteins. ten additional interacting 
proteins were added to provide a more comprehensive view of the interactions Each node represents a protein, and each 
edge represents an interaction.
(c)
(b) (d)
(e)
(a)
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functions in the cytoplasm and is frequently used as a marker 
in monitoring toxicity induced by metals21, it is a promising 
marker in ZnO NPs toxicity profiling, a potential marker for 
tumor and targets lung cancer therapeutics22. Detoxification 
system of the cell has toxic effects on proteins. Increased 
expression of HSP70 indicates the preventive measure 
induced by the cell to protect various proteins from damage by 
improper folding. 
Proteins related to stress response were found to be over 
expressed, combating against the induced oxidative stress; 
however most of the cytoskeleton related proteins like tubulin, 
actin and keratin were under expressed.  β-tubulin heterodimer 
subunits are the building blocks of microtubules, expression 
of  β-tubulin chain was three fold suppressed in cells exposed 
to ZnO NPs, indicating destabilisation of the microtubules. 
β-tubulin has microtubule stabilizing effects, under expression, 
result in shrinkage of cells as shown in Fig. 7, alteration in 
cell morphology and destabilisation of cell structure. Binding 
of the nanoparticles to tubulin could also bring permanent 
conformational alterations to the secondary structure, damage 
the microtubule polymerisation and weakening of mitochondria. 
With limited knowledge on NPs interaction with microtubules, 
the protein profile is indicative of cytoskeleton breakdown, cell 
division arrest and impaired cell motility. 
 The actin cytoskeleton is one of the major components 
of the cellular scaffold that is essential for maintaining cell 
shape and size23. Actin dynamics support a myriad of processes 
ranging from cell migration, division and morphogenesis 
to intracellular protein trafficking24. In a recent study, actin 
cytoskeleton signaling was differentially expressed when human 
lung cells were treated with CuNPs25. Gelatin nanoparticles 
were also reported to cause the F-actin cytoskeleton disruption 
and disorganisation26. Interestingly,  in our experiments it was 
clearly observed through the proteome profile that expression 
levels of  actin cytoplasmic 1 and actin cytoplasmic 2 was 
significantly reduced in cells treated with ZnO NPs. ZnO NPs 
are reported to cause  irreparable damage to the actin structure 
and actin depolymerisation27,28. ZnO NPs cause damage to 
filamentous actin due to Ca2+ ion influx29. ZnO NPs mainly 
affect cytoskeleton protein actin and tubulin because of several 
binding sites of Zn2+ ions. Cytoskeleton protein actin and 
tubulin plays a vital role in maintaining zinc homeostasis. ZnO 
NPs treated HeLa cells showed formation of actin trails and 
abnormal actin accumulation30. 
GTP binding protein Ras functions in cytoskeleton 
organisation such as membrane ruffling, pinocytosis and 
formation of stress fibers31,32. Ras associated domain-
containing protein 2, a potential tumor suppressor and Ras-
related protein Rab-6A which is involved in protein transport 
was found to be over expressed. Vimentin is an important 
marker of tumor epithelial–mesenchymal cells32 and is an 
important component of the cytoskeleton; it maintains the 
cell shape, integrity of cytoplasm, cell adhesion, and also 
involved in cell-cell interaction, cell mobility, proliferation, 
translation and transcription, apoptosis and cell signaling33. 
The proteome profile in our studies showed that expression 
level of Vimentin was reduced when A549 cells were treated 
with ZnO-NPs. The most important organelle targeted by 
ZnO-NPs is mitochondria; it is being reported that Vimentin 
influences cell movement through the mitochondria34. 
Mitochondria dysfunction could also be observed by differential 
expression of other proteins. AuNPs were reported to reverse 
the transition of epithelial-mesenchymal into cancer cells by 
down regulating vimentin35. This could also be the reason for 
reduced expression of vimentin when A549 are treated with 
ZnO-NPs, where tumor progression is impaired through a 
different pathway. Cytoskeleton plays a major role in regulating 
cell propagation and apoptosis; Keratin is one of the largest 
subgroups of intermediate filament proteins of cytoskeleton, 
with its function to protect the cell from stress36. Keratin, Type 
I and Keratin, Type II (Keratin type I cytoskeleton 10, Keratin 
type II cytoskeleton 2, Keratin cytoskeleton 7) were under 
expressed, these proteins are responsible for keratinocyte 
differentiation and activation37. NPs like CNTs, AgNPs and 
SiO2 were reported to interact with cytoskeleton proteins
36,38,39 .
In current study it was observed that ZnO NPs influence 
the expression of filamentous-Vimentin and various other 
filaments forming cytoskeleton protein like actin, tubulin and 
keratin, disturbing the cytoskeleton framework. Cytoskeleton 
proteins interact actively in the interactome, which suggests 
under-expression of these proteins affect cell’s important 
functional pathways. 
Figure 7. β-tubulin expression in A549 cells, (a) Normal cell morphology in untreated cells (b) Cells treated with 50 µg/ml ZnO NPs 
(c) Cells treated with 100 µg/ml ZnO NPs shows shrinkage and contraction.
(a) (b) (c)
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5. CONCLusION
In this paper we elucidated the interactions of ZnO NPs 
with cytoskeleton proteins. Heat shock proteins, cytoskeleton 
proteins like Keratin, Tubulin  and Actin were differentially 
expressed in ZnO NPs exposed A549 cells. Toxicoproteomics 
highlighting protein interaction with NPs as the mechanism of 
toxicity was emphasised. Interactions of ZnO NPs resulted in 
shrinkage of cells due to disrupted cytoskeleton structure.  A 
detailed understanding of mechanism of NM induced toxicity 
will facilitate the safer use of these materials in biomedicine, 
diagnostics and therapeutics.
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